Clinical Trials Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy 12 Jan 2021
25 Jan 2021 Comment Adastra eyes CRO pitches for Phase II trial of anticancer candidate; initiates $45m Series B fundraising, exec says 25 Jan 2021
22 Jan 2021 Comment Orphazyme’s arimoclomol expected to be used with Zavesca after likely FDA approval in Niemann-Pick disease type C 22 Jan 2021
29 Dec 2020 Comment Oblato open to CRO pitches for paediatric cancer candidate OKN-007, exec says 29 Dec 2020
24 Dec 2020 Comment Rigenerand engages CRO Coresearch for Phase I gene therapy study in pancreatic cancer, executive says 24 Dec 2020
